H.R. 417 (109th): Medical Innovation Prize Act of 2005
Jan 26, 2005
109th Congress, 2005–2006
Died in a previous Congress
This bill was introduced on January 26, 2005, in a previous session of Congress, but was not enacted.
Bernard “Bernie” Sanders
Representative for Vermont At Large
Read Text »
Last Updated: Jan 26, 2005
Length: 21 pages
About the bill
- Full Title
To provide incentives for investment in research and development for new medicines, to enhance access to new medicines, and for other purposes.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Referred to Committee
Last Action: Oct 19, 2007
- What is a bill?
The “H.R.” in “H.R. 417” means this is a House of Representatives bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). H.R. 417 — 109th Congress: Medical Innovation Prize Act of 2005. Retrieved from https://www.govtrack.us/congress/bills/109/hr417
“H.R. 417 — 109th Congress: Medical Innovation Prize Act of 2005.” www.GovTrack.us. 2005. March 31, 2015 <https://www.govtrack.us/congress/bills/109/hr417>
|title=H.R. 417 (109th)
|accessdate=March 31, 2015
|author=109th Congress (2005)
|date=January 26, 2005
|quote=Medical Innovation Prize Act of 2005